HPM Department News

Pitt wins federal grant to use big data and AI to help solve opioid epidemic

PITTSBURGH BUSINESS TIMES - Pitt Public Health has won a $1.2 million grant from the CDC to bring to bear its computer and algorithmic firepower on the nation's opioid epidemic. The two-year grant builds upon Pitt's modeling system called A Framework for Reconstructing Epidemiological Dynamics (FRED). "Our hope is it's the tool we can train to help" with the drug epidemic, said DEAN DONALD S. BURKE.  

Gellad on the battle to control drug costs with new patent laws

KAISER HEALTH NEWS - As congressional action seems increasingly unlikely, two approaches offer another possible path forward. The first is known as “march-in rights.” The second is generally referred to as Section 1498 because of its location in the U.S. Code. They are “already part of a law that is intact.… An option the administration can take now,” said Walid Gellad, HPM faculty member and head of Pitt's Center for Pharmaceutical Policy and P... 

Hundreds of nursing homes throughout the country forced to close their doors

NEW YORK TIMES - Fewer patients are winding up in nursing homes, and hundreds of the facilities are closing each year. Nationally, “200 to 300 nursing homes close each year,” said HPM's NICHOLAS CASTLE. The number of residents keeps shrinking, too, from 1.48 million in 2000 to 1.36 million in 2015, according to federal data.  

Fann is a new associate at Dinsmore Law Firm

NATIONAL LAW REVIEW - Alumna MELISSA FAN (HPM '12) is hired as an associate at Dinsmore Law Firm. Melissa focuses her practice on health care law, corporate law, regulatory and compliance issues and food and drug law. She received her JD from the University of Pittsburgh School of Law. Before joining the firm, Melissa interned with Judge Michael Wojcik of the Pennsylvania Commonwealth Court.  

Pittsburgh finds current liver allocation system disadvantages children awaiting liver transplants

ASPPH FRIDAY LETTER - Children are at a considerable disadvantage when competing with adults for livers from deceased organ donors in the U.S. allocation system. “Using national, long-term data, our report is the first to demonstrate that the scoring system, on its own, dramatically underestimates the risk of death in the next 90 days and, thereby, disadvantages children," says HPM chair MARK ROBERTS.  

Changing dynamics of the drug overdose epidemic in the United States from 1979 through 2016

SCIENCE - In an effort to understand the epidemic dynamics and perhaps predict its future course, Pitt Public Health researchers analyzed records of nearly 600,000 overdose deaths. Dean DONALD BURKE, HPM's HAWRE JALAL, and colleagues concluded that the U.S. drug overdose epidemic has been inexorably tracking along an exponential growth curve since at least 1979.   

Roberts and colleagues investigate how adjusting for additional clinical and social patient characteristics affects hospital readmission rates

HEALIO - According to a new study, when adjusting for additional clinical and social variables, hospital variation in readmission rates are reduced. “In several pay-for-performance programs, Medicare ties payments to readmission rates but accounts only for a limited set of patient characteristics — and no measures of social risk — when assessing performance of health care providers,” said HPM's ERIC ROBERTS, and colleagues.  

HSLS new program includes FRED

The Health Sciences Library System has created a new program called Spotlight Series: Software Developed @ Pitt. This program focuses on software developed by Pitt health sciences researchers. DAVID SINCLAIR, PHDL post-doctoral researcher/programmer, will present at the first session on “FRED: A versatile Framework for Modeling Infectious Diseases and Other Health Conditions.”   

Hernandez says drug prices rise twice as fast during shortages

HEALIO - During a shortage, drug prices increase two times as quickly as they would have in the absence of a shortage, according to findings published in Annals of Internal Medicine. “Prescription drug shortages may result in substitution of less effective drugs, delays in necessary treatments, and omission of or reductions in doses,” INMACULADA HERNANDEZ (HPM '16) and colleagues wrote.   

Children lose out on liver transplants, Pitt Public Health study finds

NBC - Children who need lifesaving liver transplants are losing out to adults. A system used to determine who is most in need of a transplant significantly underestimates the risk of death for younger children with liver disease, a Pitt Public Health study found. Senior author and HPM chair, MARK ROBERTS, said, "pediatric transplant physicians have long recognized the scoring system isn’t adequate when comparing children to adults."  

Gellad on debate about CVS' use of ICER metrics

BIOPHARMA DIVE - More than 90 organizations, predominantly patient groups, criticized CVS Caremark's decision last month to incorporate value-based drug pricing analyses in some of its coverage choices, urging the company to reconsider in a Sept. 12 letter addressed to CVS CEO Larry Merlo. HPM's WALID GELLAD told BioPharma Dive that the actual action being debated may not be so severe.  

Gellad comments on benefits that could come from the Senate opioid response vote

POLITICO - The Senate is expected to pass a sweeping opioid crisis response package this week, paving the way for a final agreement between the two chambers. Even without direct savings, patients could benefit from lowered costs of hospital-administered drugs if the hospitals use that money to increase other services, says HPM’s Walid F. Gellad, head of Pitt's Center for Pharmaceutical Policy and Prescribing.  

Gellad comments on top cancer researcher who failed to disclose corporate financial ties in major research journals

NEW YORK TIMES - One of the world’s top breast cancer doctors failed to disclose millions of dollars in payments from drug and health care companies, omitting financial ties from research articles in prestigious publications like The New England Journal of Medicine and The Lancet. HPM’s Walid F. Gellad, head of Pitt's Center for Pharmaceutical Policy and Prescribing, said, “If leaders don’t follow the rules, then we don’t really have rules."  

Miles is winner of Pittsburgh Business Times' 30 Under 30 award

PITTSBURGH BUSINESS TIMES - The winners of Pittsburgh Business Times’ 30 Under 30 awards program represent a diverse group of young professionals who are being recognized as up-and-coming executives, innovators, and thought leaders who will shape the future of Pittsburgh. ABBY MILES (HPM '13), manager of business analytics at Jewish Association on Aging is among the 2018 class.   

Gellad on Scott Gottlieb's upending FDA communication

BIOPHARMA DRIVE - Scott Gotlieb, FDA commissioner, has been very vocal on twitter as a way to communicate the FDA's goals and to invite public comment and scrutiny. Stakeholders both inside and outside the agency have given Gottlieb credit for both transparency and effort. ButWalid Gellad, HPM faculty member and head of Pitt's Center for Pharmaceutical Policy and Prescribing, said there are risks to the volume and pace of Gottlieb's methods.  

Page 10 of 31First   Previous   5  6  7  8  9  [10]  11  12  13  14  Next   Last   

Search for an Article

Share Your News

Simply click to share news of your achievements—and those of classmates or colleagues. We’re eager to hear about and share stories of student, faculty, and alumni accomplishments. Email questions to phcomm@pitt.edu
or visit publichealth.pitt.edu/sharenews.

Share news

HPM Alumni Newsletters

Read our department newsletters:

The Department is transitioning to an online newsletter format. If you would like to continue to receive a paper copy of the newsletter or if you need to update your mailing or email address, please fill out this survey

And, view the latest HPM news online!

Find news by department

Use the "Search for an article" field above to filter news by keyword, or follow the links below to view by department: